Showing 2111-2120 of 19309 results for "".
Deciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
https://reachmd.com/programs/clinicians-roundtable/deciphering-the-link-proteinuria-and-egfr-dynamics-in-igan-and-fsgs/37215/High levels of proteinuria are associated with a high risk of kidney failure in the future, both for IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). In fact, proteinuria levels can help predict disease progression, outcomes, and even optimal therapeutic approaches. Joining Dr.Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
https://reachmd.com/programs/project-oncology/modernizing-pulmonary-assessment-reassessing-race-neutral-interpretation-in-practice/39036/As medicine shifts toward race-neutral lung function interpretation, new challenges emerge in ensuring equitable access to care. Dr. Ajay Sheshadri explores how race-neutral spirometry may impact patient selection for lung resection surgery and hematopoietic cell transplantation. Dr. SheshadrDiagnosing and Treating Primary Biliary Cholangitis: Key Clinical Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-primary-biliary-cholangitis-key-clinical-insights/29157/Tune in to learn how we can improve the diagnosis and treatment of primary biliary cholangitis.Asthma Immunotherapies: Endotypes, Mechanisms, and Emerging Frontiers
https://reachmd.com/programs/Audioabstracts/immunotherapies-asthma-endotypes-mechanisms/54180/Distinct immune pathways in T2high and T2low asthma are shaping more precise therapies. To learn more, tune in as Ryan Quigley explores how endotype insights are guiding current and emerging immunotherapy strategies.Beyond Anemia: Why Iron Matters in Every Stage of Chronic Kidney Disease
https://reachmd.com/programs/clinicians-roundtable/beyond-anemia-why-iron-matters-in-every-stage-of-chronic-kidney-disease/37221/Iron deficiency in chronic kidney disease (CKD) has traditionally been addressed only in the presence of anemia. But emerging evidence and updated guidelines now support assessing and treating iron deficiency in CKD—even when anemia is not present. Here to share the latest insights from the AmericanPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
https://reachmd.com/programs/frontlines-psoriasis/pediatric-psoriasis-in-focus-emerging-insights-on-immune-and-obesity-drivers/32443/Early-onset psoriasis in children often hides in plain sight—misdiagnosed, misunderstood, and under-recognized. So to help bring clarity to its diagnosis and management, Dr. Charles Turck speaks with Dr. Amy Paller about the immunologic mechanisms that mirror adult disease, the influence of obesity,Rethinking Lupus Nephritis: Targeting Immune Dysfunction
https://reachmd.com/programs/living-rheum/rethinking-lupus-nephritis-targeting-immune-dysfunction/32819/Despite common misconceptions, lupus nephritis is part of a broader immune imbalance seen in systemic lupus, not a separate condition. This is why it's important to shift focus from organ-specific treatment to immune dysregulation targeting. Hear Dr. Joan Merrill, Professor at the Oklahoma Medical RNavigating Iron Deficiency Anemia: A Practical Guide for Gastroenterologists
https://reachmd.com/programs/gi-insights/program-name/36501/Iron deficiency anemia is common in gastroenterology patients and is often underrecognized or suboptimally managed. That's why targeted treatment is essential to improve patient outcomes. In this expert-led discussion, Dr. Peter Buch and Dr. Thomas DeLoughery outline what gastroenterologists need tTreating Psoriasis Patients Who Vape: Barriers and Interventions
https://reachmd.com/programs/clinicians-roundtable/treating-psoriasis-patients-who-vape-barriers-and-interventions/36368/For dermatologists, treating psoriasis patients who use e-cigarettes can be challenging, particularly because of a lack of education about its risks, mental health concerns, and impacts on treatment efficacy. That being said, there are ways to address these challenges to support patients and improvePatient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
https://reachmd.com/programs/project-oncology/patient-perspectives-on-subcutaneous-vs-iv-immunotherapies-in-oncology-care/36402/How do real-world patients experience subcutaneous versus IV immunotherapies? That’s exactly what a first-of-its-kind U.S. study set out to uncover. Tune in to this Audio Abstract to hear the key findings published in Oncology and Therapy and how they could reshape patient-centered cancer care. Refe